Clinical Trial

Continued Pressure for Alveolar Protection (CPAP Trial)

Study acronym: CPAP
Recruiting
View on ClinicalTrials.gov →
Summary
The objective of the CPAP Trial is to test whether extending CPAP until 34 weeks' PMA or for at least 2 additional weeks compared to weaning to a nasal canula will decrease the likelihood of bronchopulmonary dysplasia or death at 36 weeks' PMA.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-07-15
notable Trial sites expanded: 0 -> 15 locations 2026-07-15
Trial Details
NCT Number NCT07417111
Lead Sponsor NICHD Neonatal Research Network
Collaborators: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions Bronchopulmonary Dysplasia (BPD)
Enrollment 860 participants
Start Date 2026-11-05
Primary Completion 2028-11-05 (estimated)
Study Completion 2029-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-14